• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=29492214).
  
• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29492214).
  

CLPUB00440
Pirozzi G., Curci A., Errico S., Luongo V., Di Gennaro E., Caraco C., Mozzillo N., Lombardi M.L.
A new mutation of the B2-microglobuline gene in the ANAD-63, a melanoma cell line HLA class I negative.
Eur. J. Immunogenet. 28:327.260-327.260(2001)

PubMed=16638848; DOI=10.1158/1078-0432.CCR-05-1940
Scala S., Giuliano P., Ascierto P.A., Ierano C., Franco R., Napolitano M., Ottaiano A., Lombardi M.L., Luongo M., Simeone E., Castiglia D., Mauro F., De Michele I., Calemma R., Botti G., Caraco C., Nicoletti G., Satriano R.A., Castello G.
Human melanoma metastases express functional CXCR4.
Clin. Cancer Res. 12:2427-2433(2006)

PubMed=21863025; DOI=10.1038/bjc.2011.324; PMCID=PMC3185940
De Luca A., Lamura L., Strizzi L., Roma C., D'Antonio A., Margaryan N.V., Pirozzi G., Hsu M.-Y., Botti G., Mari E., Hendrix M.J.C., Salomon D.S., Normanno N.
Expression and functional role of CRIPTO-1 in cutaneous melanoma.
Br. J. Cancer 105:1030-1038(2011)

PubMed=29492214; DOI=10.18632/oncotarget.23989; PMCID=PMC5823576
Sini M.C., Doneddu V., Paliogiannis P., Casula M., Colombino M., Manca A., Botti G., Ascierto P.A., Lissia A., Cossu A., Palmieri G.
Genetic alterations in main candidate genes during melanoma progression.
Oncotarget 9:8531-8541(2018)